EA202092733A1 - PD-1 / PD-L1 INHIBITORS - Google Patents

PD-1 / PD-L1 INHIBITORS

Info

Publication number
EA202092733A1
EA202092733A1 EA202092733A EA202092733A EA202092733A1 EA 202092733 A1 EA202092733 A1 EA 202092733A1 EA 202092733 A EA202092733 A EA 202092733A EA 202092733 A EA202092733 A EA 202092733A EA 202092733 A1 EA202092733 A1 EA 202092733A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
inhibitors
cancer
alone
compositions
Prior art date
Application number
EA202092733A
Other languages
Russian (ru)
Inventor
Евангелос Актудианакис
Аесоп Чо
Майкл Грауп
Латешкумар Тхакорлал Лад
Пауло А. Мачикао Телло
Джонатан Уильям Медли
Самуэль Е. Метобо
Деван Надутхамби
Бартон В. Филлипс
Скотт Престон Симонович
Пейюань Ван
Уильям Дж. Уоткинс
Цзе Сюй
Кинь Шин Ян
Кристофер Аллен Цибенхаус
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Priority claimed from PCT/US2019/041657 external-priority patent/WO2020014643A1/en
Publication of EA202092733A1 publication Critical patent/EA202092733A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Предложены соединения и способы применения указанных соединений по отдельности или в комбинации с дополнительными агентами и композиций указанных соединений для лечения рака.Compounds and methods of using said compounds, alone or in combination with additional agents and compositions of said compounds for the treatment of cancer, are provided.

EA202092733A 2019-02-21 2019-07-12 PD-1 / PD-L1 INHIBITORS EA202092733A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962808763P 2019-02-21 2019-02-21
PCT/US2019/041657 WO2020014643A1 (en) 2018-07-13 2019-07-12 Pd-1/pd-l1 inhibitors

Publications (1)

Publication Number Publication Date
EA202092733A1 true EA202092733A1 (en) 2021-05-19

Family

ID=76160095

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092733A EA202092733A1 (en) 2019-02-21 2019-07-12 PD-1 / PD-L1 INHIBITORS

Country Status (1)

Country Link
EA (1) EA202092733A1 (en)

Similar Documents

Publication Publication Date Title
PH12021500004A1 (en) Pd-1/pd-l1 inhibitors
PH12020551244A1 (en) Pd-1/pd-l1 inhibitors
CR20190478A (en) Pd-1/pd-l1 inhibitors
EA202092590A1 (en) PYRIDAZINONES AS PARP7 INHIBITORS
MX2020012797A (en) Anti-pvrig/anti-tigit bispecific antibodies and methods of use.
WO2019222112A8 (en) Mcl-1 inhibitors
BR112018073329A2 (en) combination, pharmaceutical composition, kit, method for treating cancer, method for reducing a cell level, method for increasing activity, method for increasing cytotoxicity, method for reducing metastasis
PH12018502409A1 (en) Use of glutamate modulating agents with immunotherapies to treat cancer
BR112018073328A2 (en) combination, pharmaceutical composition, kit, cancer treatment method, cell level reduction method, cell level reduction method, activity increasing method, cytotoxicity increasing method
EA202190630A1 (en) COMBINED THERAPY METHODS
EA201792186A1 (en) INDOLAMIN-2,3-DIOXYGENASE INHIBITORS AND METHODS OF THEIR APPLICATION
EA201300171A1 (en) METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY
EA201790446A1 (en) CYTOTOXIC BENZODIAZEPINE DERIVATIVES
EA201792580A1 (en) IDO INHIBITORS
MX2023000549A (en) Combinations for the treatment of neoplasms using quiescent cell targeting and egfr inhibitors.
EA201992170A1 (en) PCSK9 EXPRESSION MODULATORS
EA202092748A1 (en) APOL1 EXPRESSION MODULATORS
PE20210109A1 (en) IRF4 EXPRESSION MODULATORS
UY38352A (en) INTEGRIN INHIBITORS ALFAVBETA6
EA202092733A1 (en) PD-1 / PD-L1 INHIBITORS
EA202193121A1 (en) CANCER TREATMENT
EA202091694A1 (en) PD-1 / PD-L1 INHIBITORS
EA201992045A1 (en) INHIBITORS PD-1 / PD-L1
EA202092239A1 (en) MCL-1 INHIBITORS
EA202191657A1 (en) EXPRESSION MODULATORS HSD17B13